8-K - CUMBERLAND PHARMACEUTICALS INC - 5.07

Form 8-K - Current report: SEC Accession No. 0001087294-26-000043

Filing Date: 2026-04-24

Accepted: 2026-04-24 17:08:24

Documents: 11

Period of Report: 2026-04-21

Items: Item 5.07: Submission of Matters to a Vote of Security Holders

CUMBERLAND PHARMACEUTICALS INC (Filer) CIK : 0001087294 (see all company filings) EIN. : 621765329 | State of Incorp.: TN | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 26895645 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | 8-K | cpix-20260421.htm iXBRL | 8-K

2 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20260421.xsd | EX-101.SCH

3 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20260421_lab.xml | EX-101.LAB

4 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20260421_pre.xml | EX-101.PRE